Skip to main content

The Myth of Cooperation

From the series Vaccines and world contention

There are by now ten authorised vaccines already in use against SARSCoV-2, and there are 77 countries in which vaccinations are taking place. By mid-February, 173 million doses had been administered and the campaign is proceeding at an average rate of six million a day, calculated on the basis of last week’s figures. At this pace, it would take 5 years to vaccinate 75% of the world population with two doses [Bloomberg, February 15th].

More than half of the injections have been carried out in the United States, the UK, and the European Union which, together, account for 11% of the world population. In at least one third of the 77 surveyed countries, less than 1% of the population have received their first dose of the vaccine, and, in the rest of the world, vaccines have not yet arrived.

Imperialist globalisation

Individual states are pursuing autonomous solutions to a global problem. Epidemiologists believe that, while a vast proportion of the population is still susceptible to the virus in the next few months, the increase in the number of persons who have been vaccinated or who have acquired natural immunity thanks to infection will produce a selective pressure that will favour the spread of new variants. These new strains will be potentially more dangerous due to increased contagiousness and virulence [Financial Times, February 9th].

It is a question of timing and internatonal coordination. Richard Horton, the editor-in-chief of The Lancet, writes that the response of govemments to COVID-19 represents the greatest political failure of Western democracies since the Second World War [The COVID-19 Catastrophe, 2020]. In his book, written in the ‘first phase’ of the pandemic, he examines the shortcomings of both the scientific community and the world leaderships, and the lessons learnt. Here we report only one of them: COVID-19 […] has also exposed our inability to cooperate, to coordinate and to act together, since national interests and rivalries have prevailed.

The need for a coordinated global effort that involves, most of all, the richest parts of the world, is highlighted by many experts and commentators. Martin Wolf of the Financial Times, paying particular attention to the economic damage the pandemic has already caused, writes that no event since the second world war has better demonstrated the limits of national autonomy and that the costs of an inward-looking policy of health in one country are not just narrowly economic. In order to halt the virus and to allow the recovery of normal trade, world leaders must do ‘whatever it takes’ to finance accelerated production and distribution of vaccines — and, if necessary, reformulated vaccines — globally, regardless of the expense, which would be incomparably less than the $5,600 billion of extra fiscal expense borne by the advanced economies in order to respond to the pandemic [February 10th].

The appeals to international cooperation are justified, even if they betray the fear that the part of the world left to itself will also drag the richer economies into the abyss, We should observe, however, that the incapacity to organise a joint, unitary action on a global scale is not a ‘dysfunction’: competition and rivalry among the economic groups, and struggles among the imperialist states for the division of spheres of interest and areas of influence, are ‘physiological’ in the capitalist social system. Unification of the world market does not mean the humankind without frontiers and class divisions; globalism does not mean internationalism.

New arrivals

On January 25th, the European Medicines Agency (EMA) authorised a third vaccine, after those of BioNTech/Pfizer and Moderna. Created by the University of Oxford, it was developed in collaboration with AstraZeneca and is already accepted in 27 other countries. AstraZeneca arose in 1999 out of the merger between the British company Zeneca and the Swedish company Astra, and is among the top ten Big Pharma companies with a $24.4 billion turnover and 70,000 employees; at the end of 2019 it was operating with 25 production sites in 16 countries. Before the pandemic it had a marginal presence in the world vaccines market.

The two-dose Oxford/AstraZeneca vaccine uses the tried and tested ‘viral vector’ technique. This technology, we recall, utilises a genetically modified virus, which is incapable of replicating itself, to transmit the genetic instructions (a fraction of the viral DNA) to human cells for the production of coronavirus spike protein. This protein will become the target of the immune system. The ‘carrier’ virus is a chimpanzee adenovirus (which causes light infections in humans such as the common cold).

According to the results made known in the latest clinical tests, the Oxford/AstraZeneca vaccine proved to be 82% effective with two doses at a distance of 12 weeks, significantly higher than with the previously observed six-week-intervalresults [The New York Times, February 319.

Political wars and trade wars

The EMA has conditionally authorised the distribution of the Oxford/AstraZeneca vaccine (pending further data from the company) for those over 18 years old. The Agency has not placed other age limits, but it has specified that there are not yet sufficient results in participants who are more than 55 years old. While this ‘recommendation’ has been adopted by other European regulatory bodies in Italy, France and Germany, the limit has been set for people who are 65 or older.

This is not the only ’stumbling block’ for Oxford/AstraZeneca. After the initial blunder regarding dosages and the intervals between the two injections, difficulties arose over respecting the delivery times of the doses promised to the European Union: these difficulties led to a commercial contention and a political clash with Britain over respecting the Brexit agreements to keep open the Irish borders.

The European Commission, under pressure from Germany, introduced controls on exports of vaccines produced in the Union in order to understand — said the German Health Minister Jens Spahn — whether the Union’s contracts with producers were being equally respected [Süddeutsche Zeitung, January 25th). The Health Commissioner Stella Kyriakides specified that the EU wants to know exactly which doses have been produced by AstraZeneca and where exactly so far and if or to whom they have been delivered. [Financial Times, January 26th]. The EU’s ‘protectionism’ came under fire from other countries such as Canada and Japan, concerned about supplies from Europe.

The slowdown in supplies — not only on the part of AstraZeneca — led to accusations being levelled against the management of vaccine supplies on the part of the EU, which centralised their anticipated purchases on behalf of all of its member states. The European Commission, argues Gideon Rachman in the Financial Times, saw the pandemic as a great opportunity to expand EU powers, showing a degree of ‘incompetence’ in handling trade agreements (February 2nd).

Vaccines and vaccinations, slower in Europe than in Britain and the United States, are being brandished in the confrontation among the powers. The Economist is even blunter: if the European Union wants to find its competitive spirit, then a vaccination race is the perfect place. For a bloc with global pretensions […] there is more at stake than health. If a group including some of the world’s most successful societies cannot vaccinate their populations swiftly, then any pretensions that the EU is a potential superpower look ridiculous [January 23rd]. This argument could be extended to the USA, a scientific and technological superpower: this giant in the scientific field has not succeeded in exploiting its knowledge within national policies in order to respond to the pandemic, writes Horton [op. cit.].

Industrial battles

In any case, the Commission has taken a step forward in European integraton, towards the realisation of a Europe de la santé Europe of the healthcarel invoked by French President Emmanuel Macron as early as May of last year. The President of the European Commission, Ursula von der Leyen, defended the centralisation of purchases, adopted to protect the smaller states who have less negotiating power with vaccine companies, but she recognised she had underestimated production problems.

Productive capacity is the crucial point. Pfizer, Moderna and AstraZeneca promised overall production of six billion doses this year. To make a comparison, the annual European production of fu shots (including Britain) is estimated by the European Federation of Pharmaceutical Industries and Associations (EFPIA) to be 1.7 billion doses, made in 27 production sites across 11 countries.

We have already observed that the strategic risk of dependence on foreign supplies in the health sector has been denounced for some time in Europe (and also in the USA). The EFPLA warns of the risk of a trade war in the new European rules: Moreover, given the global nature of vaccine supply lines, the proposal from the Commission might […] risk retaliatory measures from other regions, putting the supply of manufacturing matrials needed to produce COVID-19 vaccines and consumables related to the provision of those vaccines at risk. Retaliation measures could also extend the scope of the disruption to medicines and other products. [EFPLA, January 29th].

Thierry Breton, the European Commissioner for the Internal Market, stresses that the pandemic has increased the vulnerability of certain supply chains, and that the EU must create its own capacity in such key sectors as the pharmaceutical industry [Financial Times, May 6th]. On September 17th 2020 the European Parliament approved a resolution in which it asked the Commission to use the upcoming pharmaceutical strategy to [restore] the EU’s health independence and to increase the production of medicines and the level of innovation within the EU. Currently, 40% of the medicines on the market in the EU come from third countries [i.e., non-EU countries], while 60-80% of their active pharmaceutical ingredients are produced in China and India.

Global cooperation or global competition? The nation states are choosing ‘every man for himself’, and the Big Pharma groups are fighting for the carve-up of the world market.

Lotta Comunista, February 2021

Labels:

Popular posts from this blog

Political Battles of European Leninism

Internationalism No. 73, March 2025 Page 1 Thirty years after the death of Arrigo Cervetto , we are publishing here the concluding passages of the introduction to his Opere Scelte (“Selected Works”) for the series Biblioteca Giovani (“Publications for young people”), soon to be published in Italian. The 1944-45 partisan war in Italy. The political battle within libertarian communism. The Korean War, and the watchword of “neither Washington nor Moscow”. The layoffs at the Ilva and Ansaldo factories, the political battle and trade union defence in the struggles of post-war restructuring. From 1953 onwards, the crisis of Stalinism, the 1956 Suez crisis, the Hungarian uprising, the 1957 Theses and the challenge of theory and strategy vis-à-vis the tendencies of unitary imperialism. The political struggle within Azione Comunista (“Communist Action”) and the Movimento della Sinistra Comunista (“Movement of the Communist Left”). From the 1950s to the early 1970s, t...
Read more

The Defeat in Afghanistan — a Watershed in the Cycle of Atlantic Decline

In crises and wars there are events which leave their mark on history because of how they make a decisive impact on the power contention, or because of how, almost like a chemical precipitate, they suddenly make deep trends that have been at work for some time coalesce. This is the case of the defeat of the United States and NATO in Afghanistan, which is taking the shape of a real watershed in the cycle of Atlantic decline. For the moment, through various comments in the international press, it is possible to consider its consequences on three levels: America’s position as a power and the connection with its internal crisis; the repercussions on Atlantic relations and Europe’s dilemmas regarding its strategic autonomy; and the relationship between the Afghan crisis and power relations in Asia, especially as regards India’s role in the Indo-Pacific strategy. Repercussions in the United States Richard Haass is the president of the CFR, the Council on Foreign Relations; despite having ...
Read more

Crisis of the Order and European Question

The dialectic between economic weapons and weapons of war in the crisis in the world order requires specific reflection where concerns European imperialism. Dealing with monetary weapons in their book War by Other Means , Jennifer Harris and Robert Blackwill place great emphasis on the strategic success of the European monetary federation: Through forging the eurozone, Germany has also realized its century-long quest for a pliant European market for German manufacturing. Both of these were things it had previously tried (and failed) to accomplish by force. The long quotation below is from the speech Helmut Schmidt made to the Bundesbank Council in 1978 in favour of the EMS, the European Monetary System that would lead to the euro. Classified as confidential for 30 years, the text was declassified in 2008. There emerges from it a highly political vision of the German use of the monetary weapon and of the strategic weight of a single continental market: What now concerns German pol...
Read more

States and Courts Counterbalance Trump

Internationalism No. 73, March 2025 Page 10 From the series Chronicles of the new American nationalism Donald Trump’s political agenda has been dictated by the tempo of the dozens of executive orders, memoranda, and proclamations he has signed, challenging international partners abroad, and Congress, the States of the Union, and the bureaucracy at home. The execution of some orders has already been temporarily suspended by federal judges, while the chaos caused by a memorandum led the administration itself to withdraw it. Other rulings are expected from the courts at the request of citizens, NGOs, and States. Furthermore, as James Politi of the Financial Times notes, “the result of his political success” in the elections is that Trump will have to satisfy “a much more diverse political coalition” than in his first term. Ross Douthat, a conservative commentator for The New York Times , also believes that “at least until the Democratic Party gets up off th...
Read more

Elon Musk: Space Entrepreneur

Internationalism No. 71, January 2025 Page 12 In September 2001, Elon Musk discussed the possibility of private individuals launching space ventures with his former university classmate Adeo Ressi. In his biography of Musk, Walter Isaacson writes: “For a private individual it was obviously too expensive to build a rocket. Or was it? What were the necessary material requirements? The only thing really needed, he thought, was metal and fuel, which were not that expensive”. The two concluded that it warranted an attempt. Today, Musk is Tesla’s main shareholder and the owner of X (formerly Twitter). He is considered to be the richest man in the world and strongly supported the election of Donald Trump, whose adviser he will become. This article, however, will only deal with his activity as a space entrepreneur. Fail fast and try again In May 2002, Musk was already a millionaire after selling his Zip2 software company to Compaq when he acquired a small Califor...
Read more

The Political Form at Last Discovered

From the special series 1871-2021. The 150 th anniversary of the Paris Commune The struggle, by now more than a hundred years old, between the proletariat and the bourgeoisie encompasses the whole world. One hundred and fifty years ago, in March 1871, in a single city — Paris — and in a very short time span — 72 days — the assault on the sky attempted by the proletariat and ferociously repressed by a rising bourgeoisie resolved, in practice, fundamental theoretical issues of socialism that until that moment only had provisional solutions. In the Manifesto [1848], Marx and Engels had limited themselves to stating that the indispensable precondition for the communist revolution was the conquest of democracy , i.e., the conquest of the state machinery on the part of the proletariat. However, it remained to be seen whether and to what extent the dictatorship of the proletariat could avail itself of the bourgeois state machinery. Moreover, in the definition Lenin gives, Marx’s theo...
Read more

India’s Weaknesses in the Global Spotlight

Farmers’ protests around New Delhi have been going on for four months now. A controversial intervention by the Supreme Court has suspended the implementation of the new agticultural laws, but has raised questions about the dynamics between the judiciary and the executive, and has failed to unblock the negotiations between government and peasant organisations. The assault by Sikh farmers on the Red Fort during the Republic Day parade as India was displaying its military might to the outside world — the Chinese Global Times maliciously noted — paradoxically widened the protest in the huge state of Uttar Pradesh. The Modi government has been trying to revive India’s image with the 2021 Union Budget: it announced one hundred privatisations and approved the increase to 75% of the limit on direct foreign investment in insurance companies. For The Indian Express ( IEX ) this is a sign of the commitment to push ahead with reforms despite the backlash from rural India. Also for The Economi...
Read more

Chinese Rearmament Projects Itself in Asia

Internationalism No. 78-79, August-September 2025 Page 5 From the series Asian giants Trends in rearmament spending and comparisons of military equipment are increasingly set to dominate coverage of the contention between powers in the crisis in the world order . The military factor has entered the strategic debate, accompanied by a wealth of figures and technical details. The increase in military spending as a percentage of GDP represents a widespread sign of the rearmament cycle at this juncture, but spending alone cannot entirely explain the situation, given the qualitatively different natures of the arsenals being compared. Nor are comparisons between this or that type of weapon useful in themselves, because ultimately all weapons are only ever used in combination with the complex military means available to a power, either in alliance or in conflict with other powers in the system of States. Therefore, while it is difficult to assess the real significa...
Read more

The Hidden Costs of Covid-19

Internationalism No. 33, November 2021 Page 5 From the series The struggle against coronavirus Around 227 million people have been infected by the novel coronavirus SARSCoV-2 worldwide, causing 4.7 million deaths [Johns Hopkins University, September 17 th , 2021]. If tracked over time, both figures can be seen as indicators of the pandemic’s evolution . However, they do not give the full picture of the humanitarian disaster — not only because the coldness of the statistics hardly expresses the violence with which this health crisis has disrupted the lives of millions, but also because the official figures are believed to greatly underestimate the real situation. Missed diagnoses The number of Covid-19 cases indentified and registered in the statistics depends in fact on the number of diagnostic tests performed. It also varies greatly from country to country and in the different phases of the pandemic curve, as well as being...
Read more

Variations and Gradations of Democracy in China

Internationalism No. 50, April 2023 Page 10 From the series Giats of Asia : the dillemas of Chinese single-party pluralism Only the materialist analysis of the intraction between structure and superstructure can explain the variety of the political forms. Why did the entrenchment of the capitalist mode of production in China occur in populist and Maoist forms? Why does Chinese imperialism express itself in CP single-party pluralism and not, for example, in the classical multi-party system of imperialist democracy? This specific political analysis does not regard the study of the economic causes which determine China’s political struggles, a scientific investigation which is its premise, “but the way” in which these struggles present themselves in the superstructure. “By analysing basic economic facts, Marxism can identify at first the interests which find expression in the political struggle. The form in which these interests appear politically, however, is a qu...
Read more